HEADER HYDROLASE/HYDROLASE INHIBITOR 11-AUG-05 2ANL TITLE X-RAY CRYSTAL STRUCTURE OF THE ASPARTIC PROTEASE PLASMEPSIN 4 FROM THE TITLE 2 MALARIAL PARASITE PLASMODIUM MALARIAE BOUND TO AN TITLE 3 ALLOPHENYLNORSTATINE BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN IV; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM MALARIAE; SOURCE 3 ORGANISM_TAXID: 5858; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PLASMODIUM PARASITE, PLASMEPSIN 4, ASPARTIC PROTEASE, HYDROLASE, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.C.CLEMENTE,L.GOVINDASAMY,A.MADABUSHI,S.Z.FISHER,R.E.MOOSE, AUTHOR 2 C.A.YOWELL,K.HIDAKA,T.KIMURA,Y.HAYASHI,Y.KISO,M.AGBANDJE-MCKENNA, AUTHOR 3 J.B.DAME,B.M.DUNN,R.MCKENNA REVDAT 6 03-APR-24 2ANL 1 REMARK HETSYN REVDAT 5 11-OCT-17 2ANL 1 REMARK REVDAT 4 13-JUL-11 2ANL 1 VERSN REVDAT 3 24-FEB-09 2ANL 1 VERSN REVDAT 2 11-APR-06 2ANL 3 ATOM REMARK REVDAT 1 04-APR-06 2ANL 0 JRNL AUTH J.C.CLEMENTE,L.GOVINDASAMY,A.MADABUSHI,S.Z.FISHER,R.E.MOOSE, JRNL AUTH 2 C.A.YOWELL,K.HIDAKA,T.KIMURA,Y.HAYASHI,Y.KISO, JRNL AUTH 3 M.AGBANDJE-MCKENNA,J.B.DAME,B.M.DUNN,R.MCKENNA JRNL TITL STRUCTURE OF THE ASPARTIC PROTEASE PLASMEPSIN 4 FROM THE JRNL TITL 2 MALARIAL PARASITE PLASMODIUM MALARIAE BOUND TO AN JRNL TITL 3 ALLOPHENYLNORSTATINE-BASED INHIBITOR. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 62 246 2006 JRNL REFN ISSN 0907-4449 JRNL PMID 16510971 JRNL DOI 10.1107/S0907444905041260 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 14334 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5234 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.100 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ANL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1000034101. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14334 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10400 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: HOMOLOGY MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 15% PEG 4000 + REMARK 280 INHIBITOR, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 47.94200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 56.28950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 47.94200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 56.28950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 295 REMARK 295 NON-CRYSTALLOGRAPHIC SYMMETRY REMARK 295 THE TRANSFORMATIONS PRESENTED ON THE MTRIX RECORDS BELOW REMARK 295 DESCRIBE NON-CRYSTALLOGRAPHIC RELATIONSHIPS AMONG ATOMS REMARK 295 IN THIS ENTRY. APPLYING THE APPROPRIATE MTRIX REMARK 295 TRANSFORMATION TO THE RESIDUES LISTED FIRST WILL YIELD REMARK 295 APPROXIMATE COORDINATES FOR THE RESIDUES LISTED SECOND. REMARK 295 CHAIN IDENTIFIERS GIVEN AS "?" REFER TO CHAINS FOR WHICH REMARK 295 ATOMS ARE NOT FOUND IN THIS ENTRY. REMARK 295 APPLIED TO TRANSFORMED TO REMARK 295 TRANSFORM CHAIN RESIDUES CHAIN RESIDUES RMSD REMARK 295 SSS A 1 .. 327 B 1 .. 327 ? REMARK 295 WHERE SSS -> COLUMNS 8-10 OF MTRIX RECORDS REMARK 295 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C ASP A 110 N GLU A 112 2.18 REMARK 500 C ASP B 110 N GLU B 112 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 N LEU A 278 CB ASP B 279 3645 1.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 279 CA ASP A 279 CB -0.134 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 4 CB - CG - OD2 ANGL. DEV. = 7.2 DEGREES REMARK 500 ASP A 24 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP A 109 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 LEU A 111 N - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 ASP A 150 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 PRO A 159 C - N - CD ANGL. DEV. = -19.6 DEGREES REMARK 500 ASP A 198 CB - CG - OD2 ANGL. DEV. = 7.2 DEGREES REMARK 500 ASP A 253 N - CA - CB ANGL. DEV. = 29.0 DEGREES REMARK 500 ASP A 279 CB - CA - C ANGL. DEV. = -30.1 DEGREES REMARK 500 ASP A 303 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 ASP B 4 CB - CG - OD2 ANGL. DEV. = 7.2 DEGREES REMARK 500 ASP B 10 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP B 24 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP B 109 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 LEU B 111 N - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 ASP B 150 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 PRO B 159 C - N - CD ANGL. DEV. = -19.5 DEGREES REMARK 500 ASP B 198 CB - CG - OD2 ANGL. DEV. = 7.2 DEGREES REMARK 500 ASP B 253 N - CA - CB ANGL. DEV. = 29.0 DEGREES REMARK 500 ASP B 279 CB - CA - C ANGL. DEV. = -17.5 DEGREES REMARK 500 ASP B 303 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 2 -4.36 -50.55 REMARK 500 ASN A 3 101.95 -25.36 REMARK 500 ALA A 12 -53.50 -24.16 REMARK 500 ASN A 13 -127.88 -61.17 REMARK 500 LEU A 14 46.82 -141.58 REMARK 500 LEU A 31 -141.25 -104.95 REMARK 500 ILE A 32 112.65 -170.59 REMARK 500 LYS A 46 35.65 -72.74 REMARK 500 ASN A 48 -8.18 -143.43 REMARK 500 SER A 49 126.43 -37.14 REMARK 500 ILE A 50 -62.62 -25.72 REMARK 500 SER A 53 -66.55 -29.49 REMARK 500 SER A 65 -17.71 -165.22 REMARK 500 TYR A 66 101.58 -32.45 REMARK 500 ASP A 69 -75.15 -137.27 REMARK 500 ASP A 89 -158.19 -135.19 REMARK 500 LEU A 98 141.25 161.15 REMARK 500 THR A 106 -70.04 -111.79 REMARK 500 THR A 108 -72.66 -98.33 REMARK 500 ASP A 109 116.78 -9.48 REMARK 500 ASP A 110 -44.64 153.12 REMARK 500 LEU A 111 22.78 -75.73 REMARK 500 LEU A 114 -114.25 13.07 REMARK 500 TYR A 115 -36.11 -30.88 REMARK 500 GLU A 119 55.32 -66.32 REMARK 500 SER A 135 89.39 46.69 REMARK 500 LYS A 144 -53.72 -26.76 REMARK 500 GLN A 146 15.70 -69.13 REMARK 500 ASN A 147 71.77 34.29 REMARK 500 PRO A 159 -74.99 -109.02 REMARK 500 VAL A 160 -156.21 164.30 REMARK 500 HIS A 161 -104.74 -105.81 REMARK 500 ASP A 162 -28.17 -33.07 REMARK 500 HIS A 164 -143.75 -161.08 REMARK 500 LYS A 176 -6.54 -46.22 REMARK 500 ASP A 190 65.38 -103.21 REMARK 500 LEU A 191 -80.37 -122.52 REMARK 500 ASN A 228 -51.99 -26.31 REMARK 500 ASN A 235 71.49 38.22 REMARK 500 PRO A 240 -89.89 -37.82 REMARK 500 THR A 247 161.78 170.99 REMARK 500 ASN A 250 24.95 -67.46 REMARK 500 ASN A 251 93.10 -57.06 REMARK 500 LYS A 252 120.43 -36.99 REMARK 500 ASP A 253 89.86 94.09 REMARK 500 PRO A 276 166.24 -24.22 REMARK 500 LEU A 278 12.16 170.47 REMARK 500 ASP A 279 13.57 55.39 REMARK 500 ILE A 280 -29.30 -146.03 REMARK 500 ASP A 293 66.68 -109.43 REMARK 500 REMARK 500 THIS ENTRY HAS 110 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 11 ALA A 12 -139.77 REMARK 500 ASP A 59 SER A 60 -149.24 REMARK 500 GLU A 112 PRO A 113 84.58 REMARK 500 PRO A 113 LEU A 114 123.68 REMARK 500 LEU A 114 TYR A 115 -146.09 REMARK 500 ILE A 212 VAL A 213 -148.48 REMARK 500 LEU A 277 LEU A 278 -107.06 REMARK 500 LEU A 278 ASP A 279 126.74 REMARK 500 VAL B 11 ALA B 12 -139.74 REMARK 500 ASP B 59 SER B 60 -149.28 REMARK 500 GLU B 112 PRO B 113 84.57 REMARK 500 PRO B 113 LEU B 114 123.60 REMARK 500 LEU B 114 TYR B 115 -146.06 REMARK 500 ILE B 212 VAL B 213 -148.56 REMARK 500 LEU B 277 LEU B 278 -107.03 REMARK 500 LEU B 278 ASP B 279 126.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: (4R)-3-{(2S,3S)-2-HYDROXY-3-[(3-HYDROXY-2- REMARK 630 METHYLBENZOYL)AMINO]-4-PHENYLBUTANOYL}-5,5-DIMETHYL-N-(2- REMARK 630 METHYLBENZYL)-1,3-THIAZOLIDINE-4-CARBOXAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 JE2 A 3151 REMARK 630 JE2 B 3152 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: PF0 005 00B KNN REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JE2 A 3151 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JE2 B 3152 DBREF 2ANL A 1 327 UNP O60990 O60990_PLAMA 125 451 DBREF 2ANL B 1 327 UNP O60990 O60990_PLAMA 125 451 SEQRES 1 A 327 SER GLU ASN ASP VAL ILE GLU LEU ASP ASP VAL ALA ASN SEQRES 2 A 327 LEU MET PHE TYR GLY GLU GLY GLU VAL GLY ASP ASN HIS SEQRES 3 A 327 GLN LYS PHE MET LEU ILE PHE ASP THR GLY SER ALA ASN SEQRES 4 A 327 LEU TRP VAL PRO SER LYS LYS CYS ASN SER ILE GLY CYS SEQRES 5 A 327 SER THR LYS HIS LEU TYR ASP SER SER LYS SER LYS SER SEQRES 6 A 327 TYR GLU LYS ASP GLY THR LYS VAL GLU ILE THR TYR GLY SEQRES 7 A 327 SER GLY THR VAL ARG GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 A 327 THR LEU GLY TYR LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 A 327 VAL THR ASP THR ASP ASP LEU GLU PRO LEU TYR THR ALA SEQRES 10 A 327 ALA GLU PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 A 327 LEU SER ILE GLY SER ILE ASP PRO ILE VAL VAL GLU LEU SEQRES 12 A 327 LYS ASN GLN ASN LYS ILE ASP GLN ALA LEU PHE THR PHE SEQRES 13 A 327 TYR LEU PRO VAL HIS ASP LYS HIS SER GLY TYR LEU THR SEQRES 14 A 327 ILE GLY GLY ILE GLU GLU LYS PHE TYR GLU GLY GLU LEU SEQRES 15 A 327 THR TYR GLU LYS LEU ASN HIS ASP LEU PHE TRP GLN VAL SEQRES 16 A 327 ASP LEU ASP VAL ASN PHE GLY LYS THR SER MET GLU LYS SEQRES 17 A 327 ALA ASN VAL ILE VAL ASP SER GLY THR SER THR ILE THR SEQRES 18 A 327 ALA PRO THR SER PHE ILE ASN LYS PHE PHE LYS ASP LEU SEQRES 19 A 327 ASN VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR ILE THR SEQRES 20 A 327 THR CYS ASN ASN LYS ASP MET PRO THR LEU GLU PHE LYS SEQRES 21 A 327 SER ALA ASN ASN THR TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 A 327 MET GLU PRO LEU LEU ASP ILE ASP ASP THR LEU CYS MET SEQRES 23 A 327 LEU TYR ILE LEU PRO VAL ASP ILE ASP LYS ASN THR PHE SEQRES 24 A 327 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 A 327 PHE ASP TYR ASP LYS GLU SER ILE GLY PHE ALA VAL ALA SEQRES 26 A 327 LYS ASN SEQRES 1 B 327 SER GLU ASN ASP VAL ILE GLU LEU ASP ASP VAL ALA ASN SEQRES 2 B 327 LEU MET PHE TYR GLY GLU GLY GLU VAL GLY ASP ASN HIS SEQRES 3 B 327 GLN LYS PHE MET LEU ILE PHE ASP THR GLY SER ALA ASN SEQRES 4 B 327 LEU TRP VAL PRO SER LYS LYS CYS ASN SER ILE GLY CYS SEQRES 5 B 327 SER THR LYS HIS LEU TYR ASP SER SER LYS SER LYS SER SEQRES 6 B 327 TYR GLU LYS ASP GLY THR LYS VAL GLU ILE THR TYR GLY SEQRES 7 B 327 SER GLY THR VAL ARG GLY PHE PHE SER LYS ASP LEU VAL SEQRES 8 B 327 THR LEU GLY TYR LEU SER LEU PRO TYR LYS PHE ILE GLU SEQRES 9 B 327 VAL THR ASP THR ASP ASP LEU GLU PRO LEU TYR THR ALA SEQRES 10 B 327 ALA GLU PHE ASP GLY ILE LEU GLY LEU GLY TRP LYS ASP SEQRES 11 B 327 LEU SER ILE GLY SER ILE ASP PRO ILE VAL VAL GLU LEU SEQRES 12 B 327 LYS ASN GLN ASN LYS ILE ASP GLN ALA LEU PHE THR PHE SEQRES 13 B 327 TYR LEU PRO VAL HIS ASP LYS HIS SER GLY TYR LEU THR SEQRES 14 B 327 ILE GLY GLY ILE GLU GLU LYS PHE TYR GLU GLY GLU LEU SEQRES 15 B 327 THR TYR GLU LYS LEU ASN HIS ASP LEU PHE TRP GLN VAL SEQRES 16 B 327 ASP LEU ASP VAL ASN PHE GLY LYS THR SER MET GLU LYS SEQRES 17 B 327 ALA ASN VAL ILE VAL ASP SER GLY THR SER THR ILE THR SEQRES 18 B 327 ALA PRO THR SER PHE ILE ASN LYS PHE PHE LYS ASP LEU SEQRES 19 B 327 ASN VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR ILE THR SEQRES 20 B 327 THR CYS ASN ASN LYS ASP MET PRO THR LEU GLU PHE LYS SEQRES 21 B 327 SER ALA ASN ASN THR TYR THR LEU GLU PRO GLU TYR TYR SEQRES 22 B 327 MET GLU PRO LEU LEU ASP ILE ASP ASP THR LEU CYS MET SEQRES 23 B 327 LEU TYR ILE LEU PRO VAL ASP ILE ASP LYS ASN THR PHE SEQRES 24 B 327 ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE THR VAL SEQRES 25 B 327 PHE ASP TYR ASP LYS GLU SER ILE GLY PHE ALA VAL ALA SEQRES 26 B 327 LYS ASN HET JE2 A3151 41 HET JE2 B3152 41 HETNAM JE2 (4R)-3-{(2S,3S)-2-HYDROXY-3-[(3-HYDROXY-2- HETNAM 2 JE2 METHYLBENZOYL)AMINO]-4-PHENYLBUTANOYL}-5,5-DIMETHYL-N- HETNAM 3 JE2 (2-METHYLBENZYL)-1,3-THIAZOLIDINE-4-CARBOXAMIDE HETSYN JE2 JE-2147; AG1776; KNI-764 FORMUL 3 JE2 2(C32 H37 N3 O5 S) FORMUL 5 HOH *14(H2 O) HELIX 1 1 SER A 49 THR A 54 1 6 HELIX 2 2 PRO A 113 ALA A 118 1 6 HELIX 3 3 TRP A 128 SER A 132 5 5 HELIX 4 4 VAL A 140 ASN A 145 1 6 HELIX 5 5 GLU A 174 LYS A 176 5 3 HELIX 6 6 PRO A 223 LEU A 234 1 12 HELIX 7 7 GLU A 269 TYR A 272 5 4 HELIX 8 8 GLY A 302 LYS A 308 1 7 HELIX 9 9 SER B 49 THR B 54 1 6 HELIX 10 10 PRO B 113 ALA B 118 1 6 HELIX 11 11 TRP B 128 SER B 132 5 5 HELIX 12 12 VAL B 140 ASN B 145 1 6 HELIX 13 13 GLU B 174 LYS B 176 5 3 HELIX 14 14 PRO B 223 LEU B 234 1 12 HELIX 15 15 GLU B 269 TYR B 272 5 4 HELIX 16 16 GLY B 302 LYS B 308 1 7 SHEET 1 A 4 GLN A 27 MET A 30 0 SHEET 2 A 4 MET A 15 VAL A 22 -1 N VAL A 22 O GLN A 27 SHEET 3 A 4 VAL A 82 THR A 92 -1 O THR A 92 N GLU A 21 SHEET 4 A 4 LYS A 72 ILE A 75 -1 N ILE A 75 O VAL A 82 SHEET 1 B12 PHE A 33 ASP A 34 0 SHEET 2 B12 ILE A 123 GLY A 125 1 O LEU A 124 N ASP A 34 SHEET 3 B12 LEU A 40 PRO A 43 -1 N TRP A 41 O ILE A 123 SHEET 4 B12 PRO A 99 ASP A 107 1 O ILE A 103 N LEU A 40 SHEET 5 B12 VAL A 82 THR A 92 -1 N ASP A 89 O TYR A 100 SHEET 6 B12 MET A 15 VAL A 22 -1 N GLU A 21 O THR A 92 SHEET 7 B12 ASP A 4 VAL A 11 -1 N ASP A 9 O TYR A 17 SHEET 8 B12 GLY A 166 ILE A 170 -1 O LEU A 168 N ILE A 6 SHEET 9 B12 LEU A 153 TYR A 157 -1 N THR A 155 O THR A 169 SHEET 10 B12 TYR A 309 ASP A 314 -1 O THR A 311 N PHE A 156 SHEET 11 B12 SER A 319 ALA A 325 -1 O GLY A 321 N VAL A 312 SHEET 12 B12 TYR A 178 LYS A 186 -1 N THR A 183 O PHE A 322 SHEET 1 C 7 THR A 265 LEU A 268 0 SHEET 2 C 7 LEU A 257 LYS A 260 -1 N PHE A 259 O TYR A 266 SHEET 3 C 7 GLN A 194 PHE A 201 -1 N ASP A 198 O LYS A 260 SHEET 4 C 7 THR A 204 VAL A 213 -1 O THR A 204 N PHE A 201 SHEET 5 C 7 THR A 298 LEU A 301 1 O LEU A 301 N ILE A 212 SHEET 6 C 7 ILE A 220 ALA A 222 -1 N THR A 221 O ILE A 300 SHEET 7 C 7 ILE A 289 PRO A 291 1 O LEU A 290 N ILE A 220 SHEET 1 D 4 ILE A 237 LYS A 238 0 SHEET 2 D 4 TYR A 245 THR A 248 -1 O ILE A 246 N ILE A 237 SHEET 3 D 4 LEU A 284 LEU A 287 -1 O CYS A 285 N THR A 247 SHEET 4 D 4 MET A 274 PRO A 276 -1 N GLU A 275 O MET A 286 SHEET 1 E 4 GLN B 27 MET B 30 0 SHEET 2 E 4 MET B 15 VAL B 22 -1 N VAL B 22 O GLN B 27 SHEET 3 E 4 VAL B 82 THR B 92 -1 O THR B 92 N GLU B 21 SHEET 4 E 4 LYS B 72 ILE B 75 -1 N ILE B 75 O VAL B 82 SHEET 1 F12 PHE B 33 ASP B 34 0 SHEET 2 F12 ILE B 123 GLY B 125 1 O LEU B 124 N ASP B 34 SHEET 3 F12 LEU B 40 PRO B 43 -1 N TRP B 41 O ILE B 123 SHEET 4 F12 PRO B 99 ASP B 107 1 O ILE B 103 N LEU B 40 SHEET 5 F12 VAL B 82 THR B 92 -1 N ASP B 89 O TYR B 100 SHEET 6 F12 MET B 15 VAL B 22 -1 N GLU B 21 O THR B 92 SHEET 7 F12 ASP B 4 VAL B 11 -1 N ASP B 9 O TYR B 17 SHEET 8 F12 GLY B 166 ILE B 170 -1 O LEU B 168 N ILE B 6 SHEET 9 F12 LEU B 153 TYR B 157 -1 N THR B 155 O THR B 169 SHEET 10 F12 TYR B 309 ASP B 314 -1 O THR B 311 N PHE B 156 SHEET 11 F12 SER B 319 ALA B 325 -1 O GLY B 321 N VAL B 312 SHEET 12 F12 TYR B 178 LYS B 186 -1 N THR B 183 O PHE B 322 SHEET 1 G 7 THR B 265 LEU B 268 0 SHEET 2 G 7 LEU B 257 LYS B 260 -1 N PHE B 259 O TYR B 266 SHEET 3 G 7 GLN B 194 PHE B 201 -1 N ASP B 198 O LYS B 260 SHEET 4 G 7 THR B 204 VAL B 213 -1 O THR B 204 N PHE B 201 SHEET 5 G 7 THR B 298 LEU B 301 1 O LEU B 301 N ILE B 212 SHEET 6 G 7 ILE B 220 ALA B 222 -1 N THR B 221 O ILE B 300 SHEET 7 G 7 ILE B 289 PRO B 291 1 O LEU B 290 N ILE B 220 SHEET 1 H 4 ILE B 237 LYS B 238 0 SHEET 2 H 4 TYR B 245 THR B 248 -1 O ILE B 246 N ILE B 237 SHEET 3 H 4 LEU B 284 LEU B 287 -1 O CYS B 285 N THR B 247 SHEET 4 H 4 MET B 274 PRO B 276 -1 N GLU B 275 O MET B 286 SSBOND 1 CYS A 47 CYS A 52 1555 1555 2.05 SSBOND 2 CYS A 249 CYS A 285 1555 1555 1.97 SSBOND 3 CYS B 47 CYS B 52 1555 1555 2.05 SSBOND 4 CYS B 249 CYS B 285 1555 1555 1.97 SITE 1 AC1 11 ASP A 34 GLY A 36 TYR A 77 GLY A 78 SITE 2 AC1 11 SER A 79 LEU A 131 PHE A 192 ASP A 214 SITE 3 AC1 11 THR A 217 VAL A 292 HOH A 402 SITE 1 AC2 11 ASP B 34 GLY B 36 TYR B 77 GLY B 78 SITE 2 AC2 11 SER B 79 LEU B 131 PHE B 192 ASP B 214 SITE 3 AC2 11 THR B 217 VAL B 292 HOH B 409 CRYST1 95.884 112.579 90.404 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010429 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008883 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011061 0.00000 MTRIX1 1 -0.408904 -0.912572 -0.003283 116.80229 1 MTRIX2 1 0.912284 -0.408861 0.023900 12.99195 1 MTRIX3 1 -0.023153 0.006777 0.999709 4.22807 1